H.I.G. Capital sluit definitieve overeenkomst voor de verwerving van een meerderheidsbelang in go asia

HAMBURG, Duitsland, 12 november 2026 — H.I.G. Capital (“H.I.G.”), een toonaangevende wereldwijde investeerder in private capital met 76 miljard dollar aan beheerd kapitaal, maakt met genoegen bekend dat een gelieerde onderneming een definitieve overeenkomst heeft gesloten voor de verwerving van een meerderheidsbelang in go asia (“go asia” of de “onderneming”), de grootste winkelketen voor Aziatische levensmiddelen in Duitsland. De financiële voorwaarden van de transactie zijn niet bekendgemaakt. De transactie staat onder voorbehoud van de gebruikelijke goedkeuringen van toezichthouders.

go asia, opgericht in 2008 en gevestigd in Berlijn, heeft meer dan 70 winkels in ruim 30 steden in Duitsland. Met een assortiment van meer dan 10.000 producten uit heel Azië en ruim 1.600 medewerkers speelt de onderneming in op de groeiende vraag naar de authentieke Aziatische keuken onder een brede en gevarieerde klantenkring.

H.I.G. en de oprichtersfamilie, onder leiding van Wengui Ye, zijn overeengekomen een partnerschap aan te gaan om de volgende groeifase van de onderneming te versnellen. H.I.G. zal zijn expertise op het gebied van detailhandel en de consumentensector, zijn internationale netwerk en zijn financiële middelen inzetten om de dynamische uitbreiding van het winkelnetwerk van go asia in Duitsland en Europa te ondersteunen. De oprichtersfamilie zal herinvesteren en een aanzienlijk belang in de onderneming behouden. Oprichter Wengui Ye en het managementteam van de onderneming blijven actief betrokken bij de verdere ontwikkeling van go asia.

Wengui Ye, oprichter van go asia, verklaarde: “Toen ik in 2009 onze eerste winkel in Berlijn opende, was mijn visie om authentieke Aziatische keuken naar Duitse huishoudens te brengen. Vandaag ben ik er trots op dat go asia de grootste retailer voor Aziatische levensmiddelen in Duitsland is. Tegelijkertijd zien we nog aanzienlijke onbenutte groeimogelijkheden, niet alleen in Duitsland, maar vooral ook in heel Europa. Met zijn ruime ervaring in de detailhandel, sterke internationale netwerk en samenwerkingsgerichte, operationele aanpak is H.I.G. de ideale partner voor onze volgende groeifase. Mijn familie en ik blijven aanzienlijk geïnvesteerd in de onderneming. Ik kijk ernaar uit om samen met H.I.G. en ons uitstekende team verder vorm te geven aan de toekomst van go asia.”

Christian Kraul-von Renner, Managing Director bij H.I.G., verklaarde: “go asia is een indrukwekkend succesverhaal dat onder leiding van de oprichter tot stand is gekomen. Wengui Ye en zijn team hebben de grootste retailer voor Aziatische levensmiddelen in Duitsland opgebouwd, met een authentiek productassortiment en een onderscheidend, schaalbaar winkelconcept. We zien aanzienlijke mogelijkheden om het winkelnetwerk in Duitsland uit te breiden en daarnaast andere Europese markten te betreden. Samen met de familie Ye en het managementteam kijken we ernaar uit om de volgende groeifase van go asia te versnellen.”

Over go asia

go asia werd in 2008 door Wengui Ye in Berlijn opgericht en opende in 2009 zijn eerste winkel in de Berlijnse wijk Charlottenburg. Inmiddels is go asia met meer dan 70 winkels in ruim 30 steden en meer dan 1.600 medewerkers de grootste winkelketen voor Aziatische levensmiddelen in Duitsland. De winkels bevinden zich voornamelijk in stadscentra, winkelcentra en vervoersknooppunten. Daarnaast beschikt go asia over een webwinkel. Het assortiment van de onderneming omvat meer dan 10.000 producten uit heel Azië, van rijst, noedels, sauzen en specerijen tot diepvriesproducten en verse producten, dranken en keukengerei. Meer informatie vindt u op de website van go asia: goasia.net.

Over H.I.G. Capital

H.I.G. is een toonaangevende wereldwijde investeerder in private capital met 76 miljard dollar aan beheerd kapitaal.* H.I.G. is gevestigd in Miami en heeft kantoren in Atlanta, Boston, Chicago, Los Angeles, New York, San Francisco en Stamford in de Verenigde Staten, evenals internationale kantoren van gelieerde ondernemingen in Hamburg, Londen, Luxemburg, Madrid, Milaan, Parijs, Bogotá, Rio de Janeiro, Dubai en Hongkong. H.I.G. is gespecialiseerd in het verstrekken van zowel schuld- als aandelenkapitaal aan middelgrote ondernemingen en hanteert daarbij een flexibele, operationeel gerichte en waardetoevoegende aanpak:

  • De aandelenfondsen van H.I.G. investeren in management buy-outs, herkapitalisaties en corporate carve-outs van zowel winstgevende als ondermaats presterende productie- en dienstverlenende ondernemingen.
  • De schuldfondsen van H.I.G. investeren in senior-, unitranche- en juniorfinanciering aan ondernemingen van uiteenlopende omvang, zowel via rechtstreekse kredietverstrekking op de primaire markt als via de secundaire markten.
  • De vastgoedfondsen van H.I.G. investeren in value-added vastgoed dat baat kan hebben bij verbeterd assetmanagement.
  • H.I.G. Infrastructure richt zich op value-add- en core-plusinvesteringen in de infrastructuursector.

Sinds de oprichting in 1993 heeft H.I.G. wereldwijd in meer dan 400 ondernemingen geïnvesteerd en deze beheerd. De huidige portefeuille van H.I.G. omvat meer dan 100 ondernemingen met een gezamenlijke omzet van meer dan 53 miljard dollar. Meer informatie vindt u op de website van H.I.G. hig.com.

*Op basis van het totale kapitaal dat H.I.G. Capital en zijn gelieerde ondernemingen hebben aangetrokken.

Contact:

Christian Kraul-von Renner
Managing Director
[email protected]

H.I.G. European Capital Partners GmbH
Warburgstrasse 50
20354 Hamburg
Duitsland
Tel.: +49 40 41 33 06 100
hig.com

Eli Radiopharma Completes Series A Financing of Nearly RMB 400 Million to Advance Innovative Radiopharmaceutical Pipeline Toward Clinical Development

HANGZHOU, China, Nov. 11, 2026 — Hangzhou Eli Radiopharma Co., Ltd. (“Eli Radiopharma”, or “the Company”), an innovative radiopharmaceutical company focused on integrated diagnostics and therapeutics for oncology and neurological diseases, today announced the completion of a Series A financing round of nearly RMB 400 million. The round was led by Huagai Capital, with Bayland Capital as co-lead investor, and participation from Boyu Ventures, Delian Capital, InnoPinnacle Fund, Haibang Venture, Bairui Capital, Shenzhen Angel FOF Management, and Grand Flight Investment. Existing shareholders CSPC & Growth Bio Fund, Huaige Capital, KHK Fund, Longfeng Venture, Hongsheng Capital, Bioclub Fund, and Skyfield Capital also participated in the round.

The proceeds will primarily support the advancement of the Company’s core innovative pipeline toward clinical development. Funding will be directed toward preclinical research, clinical trial applications, and early-stage clinical development, alongside further investment in R&D platforms, talent acquisition, and the Company’s clinical and business development. The financing will provide strong support for the continued advancement of the Company’s pipeline and its long-term growth. To date, the Company has advanced multiple programs targeting novel molecular targets through lead discovery and in vitro and in vivo validation, with promising target specificity and drug development potential. Several programs are approaching IND submission.

“The completion of this financing round marks an important milestone in Eli Radiopharma’s development and reflects our investors’ confidence in our R&D strategy, technological capabilities, and long-term vision,” stated Dr. Feng Yu, Founder and CEO of Eli Radiopharma. “Moving our pipeline toward the clinic is a critical next step in translating our research into meaningful advances for patients. This financing will support our efforts to advance our lead programs through preclinical development and regulatory milestones, bringing differentiated radiopharmaceutical candidates closer to clinical evaluation. We remain focused on addressing unmet clinical needs and strengthening our R&D and clinical development capabilities, with the goal of delivering precision diagnostic and therapeutic options for patients with cancer and neurological diseases.”

Cynix Wang, Chief Investment Officer of Healthcare at Huagai Capital, said, “Radiopharmaceuticals represent an exciting area of innovation at the intersection of molecular targeting, radionuclide technology, and precision theranostics. As the field continues to advance, expanding clinical applications, progress in therapeutic radionuclides, and the development of novel targets and differentiated pipelines are creating new opportunities for the radiopharmaceutical industry. The two BD deals in 2026 involving multinational pharmaceutical companies and Chinese radiopharmaceutical innovators further underscore the growing global recognition of China’s innovation capabilities and the significant potential for international partnerships. We are encouraged by Eli Radiopharma’s focused approach to radiopharmaceutical R&D and its ability to advance novel candidates into clinical development. Our investment reflects our confidence in the Company’s scientific capabilities and long-term potential. We look forward to supporting the advancement of its pipeline and helping translate promising science into clinical applications, while contributing to the broader advancement of the radiopharmaceutical field.”

Xi Zou, Director and Project Lead at Bayland Capital, commented: “Bayland Capital has long been closely following innovations in the global radiopharmaceutical sector and strongly recognizes the clinical value and growth potential of radioligand therapy (RLT). We believe that, as more innovative therapies gain regulatory approval, RLT will play an increasingly important role in the treatment of a broad range of solid tumors. Eli Radiopharma has demonstrated distinct competitive strengths in its R&D strategy, innovation capabilities, and development efficiency. The company continues to expand its team, strengthen its technology and development capabilities, and steadily advance its global strategy. We are confident in Eli Radiopharma’s potential to build a globally competitive pipeline of innovative radiopharmaceuticals and deliver meaningful clinical value in international markets, including the US and Europe. Bayland Capital is delighted to co-lead this financing round. Looking ahead, we will continue to support Eli Radiopharma in expanding its technology platforms, accelerating the clinical development of its lead programs, and advancing differentiated, globally competitive radiopharmaceuticals, helping bring China-originated innovation to patients worldwide.”

Yilun LIU, Partner of Boyu Ventures, said, “Radiopharmaceuticals hold significant potential to advance precision diagnostics and therapeutics. Eli Radiopharma is building a differentiated pipeline targeting oncology and neurological diseases with a clear focus on addressing unmet clinical needs. We believe the Company’s scientific expertise and R&D capabilities provide a strong foundation for advancing its pipeline toward clinical development. We look forward to seeing Eli Radiopharma progress its innovative programs and translate its research into meaningful clinical value for patients.”

About Huagai Capital

Huagai Capital was founded in 2012 as a private equity investment firm jointly established by a group of professionals from leading investment institutions in China and overseas. With the vision of “becoming the most trusted capital partner for entrepreneurs and investors”, the firm focuses on the two major sectors of healthcare and technology and is committed to helping small and medium-sized enterprises grow into industry leaders. Its cumulative assets under management stand at approximately RMB 35 billion, and it has successfully cultivated 34 listed companies.

About Bayland Capital

Established in 2019 and backed by Pharmaron, Bayland Capital is a life sciences-focused investment firm with a global investment perspective. Leveraging Pharmaron’s industry expertise and the team’s extensive experience in scientific research, business management, and capital markets, Bayland Capital invests in leading life sciences R&D service providers, innovative technology platforms, biotechnology companies, and medical device companies worldwide. Bayland Capital is committed to serving as a bridge connecting life sciences innovation, the healthcare industry, and capital, and to being a trusted long-term partner in advancing healthcare innovation.

About Boyu Ventures

Boyu Ventures was co-founded by Boyu Capital together with young entrepreneurs and seasoned investors, with a focus on early-stage investments in frontier technology and life sciences. Drawing fully on Boyu’s strengths in capital, industry expertise, insight, and organizational capability, Boyu Ventures brings together resources to empower its portfolio companies, standing alongside founders as they navigate fast-changing markets and build for long-term success. Boyu Ventures firmly believes that a diverse team sparks fresh thinking and brings complementary strengths, enabling it to uncover the most compelling investment opportunities in an ever-changing world. The firm is dedicated to discovering entrepreneurs with a genuine capacity for original innovation, and to partnering with them as they grow into cornerstones of the new economy.

About Delian Capital

Founded in 2011, Delian Capital has consistently focused on investments in technology and innovative healthcare. The firm targets key sectors such as Intelligent Equipment, Artificial Intelligence (AI), Semiconductors, Energy Technology, Innovative Drugs, Medical Technology (MedTech), and Neuroscience.Delian Capital has invested in over 100 projects,including Rokae Robotics, Mech-Mind, X-Square, DIFY.AI, Silicontent, ARCHIWAVE, Macrotest , Zendure, VelaVigo, AMUNIX, Venus Medtech, Core Medical, Mindtrix, and BCI-SONICS.

About InnoPinnacle Fund

Started in 2021, InnoPinnacle Fund is a specialist biotech VC fund established by Innovent Biologics, a leading biopharmaceutical company listed on Hong Kong Stock Exchange (HKEX. 01801). InnoPinnacle focuses on high-growth opportunities in the biotech sector. We aim to accelerate groundbreaking innovations in life sciences to improve human health, while establishing ourselves as the premier global biotech-focused investor.

About Haibang Venture

Connecting Global Talent with Opportunities to Build and Innovate. Haibang Venture founded in 2011, is China’s first venture capital firm dedicated to supporting entrepreneurship among overseas-returned talent. Haibang Venture manages nearly 40 funds with approximately RMB 8 billion in assets under management. It has invested in over 160 companies, nearly 100 of which were founded by high-caliber talent, with 29 achieving IPOs or M&A exits. Guided by its “Talent + Technology” investment philosophy, Haibang Venture focuses on life sciences and healthcare, information technology, and advanced materials and high-end manufacturing, investing primarily in hard-tech ventures founded by outstanding talent from China and abroad and aligned with China’s strategic emerging industries.

About Shenzhen Angel FOF Management

Shenzhen Angel FOF Management Co., Ltd. (“Shenzhen Angel FOF Management”) was jointly established by Shenzhen Investment Holdings Co., Ltd. and Shenzhen Capital Group Co., Ltd. Guided by its mission to “invest early, invest small, and invest in hard technology,” Shenzhen Angel FOF Management embraces long-termism and fosters patient capital, operating three core business lines: sub-fund investment, direct investment, and innovation ecosystem development. It manages the largest angel investment government guidance fund in China, with over 100 sub-funds launched and more than 1,000 technology companies empowered.

About Bairui Capital

Bairui Capital is an early-stage venture capital dedicated to backing disruptive innovation with a long-term investment vision. We invest in frontier technology sectors, including AIGC & infrastructure, embodied intelligence, and AI-powered life sciences. We seek to identify and capture the most consequential technological shifts of our time, with a particular focus on emerging computing paradigms that are fundamentally reshaping both software and hardware.

About Grand Flight Investment

Grand Flight Investment is an alternative investment platform sponsored principally by Far East Horizon (HKEX: 3360) and managed by a dedicated team of investment professionals. Guided by its core investment philosophy — “Finance Empowers Growth, Industry Creates Value” — the firm invests in high-quality, growth-stage companies in China, focusing on healthcare, commercial aerospace, and embodied AI. Post-investment, it works closely with portfolio companies to connect them with the financial and industry resources they need to create value.

About Eli Radiopharma

Eli Radiopharma, founded in 2024, is a radiopharmaceutical company focused on the innovation and development of next-generation radiopharmaceuticals and advanced technology applications. Driven by its core value of “innovation-driven precision medicine”, Eli Radiopharma is dedicated to delivering theranostic solutions for oncology and neurological diseases. By combining molecular targeting with radionuclide technology, the Company is committed to developing safe and cutting-edge radiopharmaceuticals to enable precise diagnostics and effective treatments, ultimately improving the health and longevity of patients worldwide.

SOURCE Hangzhou Eli Radiopharma Co., Ltd.

H.I.G. Capital unterzeichnet endgültige Vereinbarung zum Erwerb einer Mehrheitsbeteiligung an go asia

HAMBURG, Deutschland, 11. November 2026 — H.I.G. Capital („H.I.G.”), eine weltweit führende Gesellschaft für alternative Anlagen mit einem verwalteten Kapital von 76 Milliarden US-Dollar, freut sich bekannt zu geben, dass eines ihrer verbundenen Unternehmen eine endgültige Vereinbarung zum Erwerb einer Mehrheitsbeteiligung an go asia („go asia” oder das „Unternehmen”), Deutschlands größter Einzelhandelskette für asiatische Lebensmittel, unterzeichnet hat. Die finanziellen Bedingungen der Transaktion wurden nicht bekannt gegeben. Die Transaktion unterliegt den üblichen behördlichen Genehmigungen.

go asia wurde 2008 gegründet, hat seinen Hauptsitz in Berlin und betreibt über 70 Filialen in mehr als 30 Städten in ganz Deutschland. Mit einem Sortiment von über 10 000 Produkten aus ganz Asien und mehr als 1600 Beschäftigten bedient das Unternehmen die wachsende Nachfrage einer breit gefächerten Kundschaft nach authentischer asiatischer Küche.

H.I.G. und die Gründerfamilie unter der Führung von Wengui Ye haben eine Partnerschaft vereinbart, um die nächste Wachstumsphase des Unternehmens zu beschleunigen. H.I.G. wird sein Fachwissen im Einzelhandel und Konsumgüterbereich, sein internationales Netzwerk sowie seine finanziellen Mittel einbringen, um den dynamischen Ausbau des Filialnetzes von go asia in Deutschland und Europa zu unterstützen. Die Gründerfamilie wird erneut in das Unternehmen investieren sowie weiterhin eine bedeutende Beteiligung daran halten und Gründer Wengui Ye sowie das Führungsteam des Unternehmens werden die Zukunft von go asia auch künftig aktiv mitgestalten.

Wengui Ye, Gründer von go asia, kommentierte: „Als ich 2009 unseren ersten Laden in Berlin eröffnete, war es meine Vision, authentische asiatische Küche in deutsche Haushalte zu bringen. Heute bin ich stolz darauf, dass go asia Deutschlands größter Einzelhändler für asiatische Lebensmittel ist – und wir sehen weiterhin erhebliches ungenutztes Wachstumspotenzial in Deutschland sowie insbesondere in ganz Europa. Mit seiner umfassenden Erfahrung im Einzelhandel, seinem starken internationalen Netzwerk sowie seinem partnerschaftlichen und praxisorientierten Ansatz ist H.I.G. der ideale Partner für unsere nächste Wachstumsphase. Meine Familie und ich werden weiterhin in erheblichem Umfang am Unternehmen beteiligt sein, und ich freue mich darauf, die Zukunft von go asia gemeinsam mit H.I.G. sowie unserem hervorragenden Team auch künftig mitzugestalten.”

Christian Kraul-von Renner, geschäftsführender Leiter bei H.I.G., erklärte: „go asia steht für eine beeindruckende Erfolgsgeschichte unter der Führung seines Gründers. Wengui Ye und sein Team haben mit einem authentischen Sortiment und einem unverwechselbaren, skalierbaren Filialkonzept Deutschlands größte Einzelhandelskette für asiatische Lebensmittel aufgebaut. Wir sehen erhebliches Potenzial für den Ausbau des Filialnetzes in Deutschland sowie für den Eintritt in andere europäische Märkte. Gemeinsam mit der Familie Ye und dem Führungsteam freuen wir uns darauf, die nächste Wachstumsphase von go asia zu beschleunigen.”

Informationen zu go asia

go asia wurde 2008 von Wengui Ye in Berlin gegründet und eröffnete 2009 seine erste Filiale in Berlin-Charlottenburg. Heute ist go asia mit über 70 Filialen in mehr als 30 Städten und über 1600 Beschäftigten Deutschlands größte Einzelhandelskette für asiatische Lebensmittel. Die Filialen befinden sich überwiegend in Stadtzentren und Einkaufszentren sowie an Verkehrsknotenpunkten, wobei das Filialnetz durch einen Online-Shop ergänzt wird. Das Sortiment des Unternehmens umfasst über 10 000 Produkte aus ganz Asien, von Reis, Nudeln, Soßen und Gewürzen bis hin zu Tiefkühl- und Frischprodukten, Getränken sowie Küchenutensilien. Weitere Informationen finden Sie auf der Website von go asia goasia.net.

Informationen zu H.I.G. Capital

H.I.G. ist eine weltweit führende Gesellschaft für alternative Anlagen mit einem verwalteten Kapital von 76 Milliarden US-Dollar.* Mit Hauptsitz in Miami und Niederlassungen in Atlanta, Boston, Chicago, Los Angeles, New York, San Francisco sowie Stamford in den Vereinigten Staaten und Büros verbundener Unternehmen in Hamburg, London, Luxemburg, Madrid, Mailand, Paris, Bogotá, Rio de Janeiro, Dubai sowie Hongkong ist H.I.G. auf die Bereitstellung von Fremd- und Eigenkapital für mittelständische Unternehmen spezialisiert und verfolgt dabei einen flexiblen Ansatz, der auf betriebliche Verbesserungen sowie Wertsteigerung ausgerichtet ist:

  • Die Eigenkapitalfonds von H.I.G. investieren in Management-Buy-outs, Rekapitalisierungen und Ausgliederungen von profitablen sowie leistungsschwachen Produktions- und Dienstleistungsunternehmen.
  • Die Fremdkapitalfonds von H.I.G. investieren in vorrangige, Unitranche- und nachrangige Fremdfinanzierungen für Unternehmen unterschiedlicher Größenklassen, sowohl im Primärmarkt (direkte Kreditvergabe) als auch an den Sekundärmärkten.
  • Die Immobilienfonds von H.I.G. investieren in Aufwertungsobjekte, die von verbesserten Asset-Management-Verfahren profitieren können.
  • H.I.G. Infrastructure konzentriert sich auf Investitionen mit Wertsteigerungspotenzial sowie Core-Plus-Investitionen im Infrastruktursektor.

Seit der Gründung im Jahr 1993 hat H.I.G. weltweit in mehr als 400 Unternehmen investiert und diese betreut. Das aktuelle Portfolio der Gesellschaft umfasst mehr als 100 Unternehmen mit einem Gesamtumsatz von über 53 Milliarden US-Dollar. Weitere Informationen finden Sie auf der H.I.G.-Website hig.com.

*Basierend auf dem gesamten von H.I.G. Capital und seinen verbundenen Unternehmen eingeworbenen Kapital.

Kontakt:

Christian Kraul-von Renner
Geschäftsführender Leiter
[email protected]

H.I.G. European Capital Partners GmbH
Warburgstraße 50
20354 Hamburg
Deutschland
Tel.: +49 40 41 33 06 100
hig.com

Helix Secures $6.2 Million in Pre-Seed Capital and Launches Voice-Based Human Verification for the AI Era

Helix accurately detect bots and predict age using voice samples in under four seconds

Helix advisors include Dag Kittlaus, co-creator and CEO of Siri

LOS ANGELES, Nov. 11, 2026 — Helix, a voice-powered human verification platform, today announced it has raised $6.2 million in funding and is now live with its first partners. Helix offers biometric-based identity and age verification in under four seconds, with no data ever leaving the user’s phone.  The round was led by Chicago Ventures, with participation from BAM Ventures, Aglaé Ventures, Corazon Capital, Tusk Ventures, Yonder Ventures, Rule30, Press On Ventures, and Brown Angel Group.

“We built Helix to restore trust in every digital interaction. Right now, consumers are scared of having their personal information stolen online, while platforms fight a losing battle against AI to prove whether an account is a real adult or a synthetic agent,” said Alex Oberg, CEO and co-founder of Helix. “The traditional approach has been to collect reams of sensitive data, ranging from uploaded driver’s licenses to video selfies, which is both cumbersome for customers and puts their privacy at risk. Helix solves these problems by using voice to verify identity and doing so entirely on-device. As we confront a new era of AI fakes and agent proliferation, we are eager to introduce our patented solution and contribute to a safer, more human-powered internet.”

“We’ve spent years teaching machines to understand words. Helix is teaching them to understand the person speaking — and to do it in a way people can trust,” said Dag Kittlaus, cofounder and CEO of Siri, cofounder and CEO of Viv.

The Problem Helix is Built to Solve: According to Cloudflare, bots now make up more than 57% of all web traffic. As agents have increased, so too have stories of agents acting without human authorization, from hacking critical websites to accessing customer bank accounts. Generative AI has increased the frequency and sophistication of romance scams, identity theft, and underage access to age-restricted platforms, with generative AI-enabled fraud costing U.S. companies more than $40 billion by 2027. In response, companies have been forced to choose between lower friction, but lower effectiveness solutions like CAPTCHA and SMS or expensive and cumbersome solutions like video selfies — both of which still fall short of stopping today’s fraud capabilities.

Helix’s Cutting-Edge Solution: Helix verifies that users are human through a simple, four number voice challenge, providing biometric-level security with the low cost and friction of SMS multi-factor authentication. Helix offers their Biometric MFA and Age Assurance entirely on device, without storing any biometric data or other personally identifiable information (PII) on any server. The unique zero-PII architecture can be deployed across verticals ranging from ticketing, to dating, gaming, gambling and fintech. Platforms can integrate with Helix through either a software development kit (SDK) or via a single line in Claude Code or OpenAI Codex deployments.

The External Standards and Certifications Secured by Helix: Helix is also one of the only audio companies in the world that meets the stringent ISO/IEC 27566-1:2025, an international standard for age assurance systems, and is fully accredited by the Age Check Certification Scheme (ACCS), a rigorous, independent, third-party auditor. Helix is also one of the first companies certified under the IEEE Online Age Verification Certification Program, which is the framework used by New York’s SAFE for Kids Act, taking effect January 2027. This new law requires independently certified, highly effective age assurance and at least one option that does not require a government ID for all platforms with an algorithmically driven feed. Helix’s approach, voice, fits that exactly.

Helix’s Launch Partner: Helix is currently in beta with early partners, such as Zeel, a leading in-home health and wellness platform, as an additional measure for their verification processes.

“The Trust and Safety landscape is changing quickly, particularly as AI creates new challenges around identity and verification,” said Samer Hamadeh, founder and CEO of Zeel. “At Zeel, we believe it’s important to continually evaluate new approaches to strengthening trust. Helix is one of the technologies we’re exploring as we think about how Trust and Safety needs to evolve for the AI era.”

“Combatting bots has remained one of the biggest and toughest challenges facing the ticketing industry. In spite of the myriad of tools and defenses we employed at Ticketmaster, it remained a continuous arms race that will require new approaches in AI era. The voice-powered capabilities being employed by Helix are one of the most unique and effective approaches I’ve seen to make a real improvement for people and platforms in all sectors online,” said Jared Smith, former President and Global Chairman at Ticketmaster and Helix board member and investor. 

“AI has fundamentally changed the landscape of fraud and impersonation, exposing the limitations of legacy approaches to identity and human verification. Helix is redefining human verification through voice – seamless for consumers, privacy-first, and purpose-built for the AI era. Alex and the team bring deep expertise solving identity and trust challenges at scale, and we believe Helix is building critical infrastructure for digital trust,” said Eric Duboe, Partner at Chicago Ventures.

ABOUT HELIX

Helix is a voice-enabled human verification company created for the AI era. Through one SDK integration, Helix offers Bot Management, Biometric MFA, and Age Assurance, all built on the same privacy-by-architecture principles where zero data ever leaves a user’s device. Founded by engineers from Ticketmaster, Tinder, and Zillow, Helix’s mission is to restore trust in every digital interaction. Helix is backed by Chicago Ventures, BAM Ventures, Aglaé Ventures, Corazon Capital, Tusk Ventures, Yonder Ventures, Rule30, Press On Ventures and Brown Angel Group. For more information, visit https://helix.id/.

SOURCE Helix

Coreshell Technologies Raises $30M Series B to Scale China-Free Batteries for U.S. Industries

Round co-led by Ferroglobe and Access Industries builds on $50M DOE grant to accelerate commercialization of batteries made with domestic critical materials

SAN LEANDRO, Calif., Nov. 11, 2026 — Coreshell Technologies, a battery technology company, today announced the close of a $30 million Series B financing round co-led by Ferroglobe PLC (NASDAQ: GSM) and Access Industries, with participation from ADS, Helios Ventures, Pegasus Tech Ventures, Mana Ventures, and Entrada Ventures. The funding will accelerate the commercialization and scale-up of Coreshell’s battery technology, support expansion of manufacturing and customer programs, and advance its goal of eliminating dependence on China for critical battery materials across both the anode and cathode supply chains.

This round builds on significant public-sector support for Coreshell’s domestic battery manufacturing efforts, including a $50 million grant from the Department of Energy in August.

The financing comes as U.S. manufacturers across defense, automotive, data centers, and other key industries look to strengthen supply-chain resilience and secure access to domestic sources of critical materials. Federal sourcing requirements, including those under the National Defense Authorization Act (NDAA), along with new procurement policies and White House measures, are accelerating that shift, particularly in defense, where compliance alone may not protect manufacturers from supply-chain disruptions.

Graphite is a critical component of conventional lithium-ion batteries, and more than 90 percent of the world’s graphite is processed in China. This concentration leaves battery manufacturers and their customers vulnerable to disruptions beyond their control.

 In 2023, China tightened controls on graphite exports, underscoring the risks of relying on a concentrated source for a critical battery material. Coreshell eliminates that vulnerability by replacing graphite entirely with metallurgical silicon (MGS), a widely available, low-cost material produced in the US.

“Meeting sourcing requirements is an important step, but it doesn’t necessarily mean a battery supply chain is secure, no matter what industry you’re in,” said Jonathan Tan, CEO and Co-Founder of Coreshell Technologies. “This new financing gives us the resources to scale a battery supply chain that eliminates dependence on China for critical materials while delivering advantages in performance and cost.”

That effort is already underway. Coreshell is using its $50 million federal grant to build the first giga-scale factory for cells using MGS anodes, vastly expanding domestic production of this critical battery technology.

“As uncrewed systems become increasingly important to the future of American defense, the batteries powering those systems cannot be a geopolitical liability,” said Dave Bellis, Manager of Corporate Strategy and Development at ADS, the top supplier to the Defense Logistics Agency. “Coreshell has a differentiated technology and a supply chain designed around domestic critical minerals, giving the defense industry a path toward batteries that are both high-performing and genuinely secure.”

A Battery Technology Built Around Domestic Materials

Coreshell replaces conventional graphite with metallurgical silicon (MGS), a raw, commercially produced form of silicon that differs from the expensive, silane-based materials used in other silicon-anode cells. Coreshell’s MGS anode leverages silicon’s performance and cost advantages while using an abundant, domestically sourced material. On the cathode side, an agreement with L&F Co., Ltd provides long-term access to lithium, enabling Coreshell to produce batteries free of Chinese critical materials.

About Coreshell Technologies, Inc.

Coreshell Technologies develops high-performance batteries designed to eliminate dependence on Chinese critical minerals. Its proprietary battery technology replaces conventional graphite in lithium-ion batteries with American metallurgical silicon (MGS), delivering higher performance at lower cost while enabling a domestic supply chain. Headquartered in San Leandro, California, Coreshell works with battery manufacturers, automotive OEMs, defense customers and other organizations seeking more secure energy storage solutions. For more information, visit www.coreshell.com.

SOURCE Coreshell Technologies

Vine Ventures Closes $236 Million Fund III to Back the U.S.-Israel Technology Corridor

Fund III is Vine’s largest fund to date and has surpassed its initial target, backed by new and returning limited partners

TEL AVIV, Israel, Nov. 11, 2026 — Vine Ventures, a venture capital firm partnering with category-defining companies across the U.S.–Israel technology corridor, today announced the close of its $236 million Fund III. The fund surpassed its initial target and is Vine’s largest to date, bringing the firm’s total assets under management to over $500 million just five years after its founding.

Fund III is backed by a group of limited partners that includes global asset managers, family offices, and senior executives of global companies

Since the close of its previous fund, Vine has sharpened its focus on Israel, deepening its on-the-ground presence and sourcing while retaining the international mandate and U.S. footprint that have defined the firm since inception. Fund II, for example, holds positions from seed in Eon, Wonderful, and Ornn. Fund III will extend that approach, backing category-defining companies across the corridor.

“We’re not simply investing in Israel, we’re allocating capital across the strategic corridor between the two most important technology ecosystems in the world,” said Eric Reiner, Founder and Partner of Vine Ventures. “America brings capital, scale, and the frontier models. Israel builds the layer underneath that makes the technology actually work, in addition to the application, defense, and cyber layer, where we have invested heavily. Our approach is to reach deep into both and connect them in ways that set us apart.”

Alongside the new fund, Vine has formed a senior advisory group of business leaders in the U.S. Joining as senior advisors are Michael Lynton, Chairman of Snap Inc. and former CEO of Sony Entertainment, Gary Reiner, former Chief Information Officer at General Electric and most recently Operating Partner at General Atlantic, and Bob Mylod, Chairman of booking.com. Vine has also expanded its investment team with Adam Valkin, formerly of General Catalyst, who leads the firm’s investing from Boston, and Idan Tendler, formerly of Palo Alto Networks.

“At Vine, we have always believed in the power of focused, hands-on partnerships with founders to generate exceptional outcomes, and the investments from Fund III will continue to embody that philosophy,” added Reiner. “Our LPs believe that with the strength of our portfolio, alongside the additions of Adam, Michael, and Idan, who bring a wealth of experience, that Vine is just getting started, and intends to continue to pursue multi-billion-dollar opportunities at their earliest stages.”

About Vine Ventures

Vine Ventures is a global venture capital firm with a focus on early and growth-stage investments in transformative technology sectors. The firm aims to back bold founders and category-defining companies across the U.S., Israel, and Europe. With over $500 million across three funds, Vine is committed to fueling the next generation of innovators in enterprise software, AI infrastructure, cybersecurity, and financial technology. For more information, please visit https://vineventures.com/

Media Contact
Raanan Loew
[email protected] 
US: +1 347 897 9276

SOURCE Vine Ventures L.P.

Plurai raises $13M to build the simulation infrastructure for trustworthy, self-improving AI agents

  • Platform now available to all developers, after it cut design partners’ development cycles from months to hours, reduced costs by 97% and failures by 82%
  • Round led by Team8, with backing from CyberArk founder Udi Mokady, and Google and Microsoft executives
  • Joint work with NVIDIA and Nebius for a global enterprise customer outperformed OpenAI and Anthropic frontier models on accuracy at ~44x lower cost

NEW YORK, Nov. 11, 2026 — Plurai, the simulation infrastructure for trustworthy, self-improving AI agents, today announced $13M in seed funding and the general availability of its platform. The platform helps enterprises find and fix failures before their agents reach customers, then keeps them reliable, accurate and cost-efficient in production with small language models (SLMs) tailored to each agent’s tasks. Plurai has cut design partners’ agent development cycles from months to hours, reduced failures reaching real users by 82% and lowered the cost of running reliable agents by 97%. In joint work with NVIDIA and Nebius, models Plurai post-trained for a global enterprise customer outperformed OpenAI and Anthropic frontier models on accuracy at 40x and 44x lower cost, respectively.

The round was led by Team8, with participation from U&I, Velocity and Mercer, and backing from more than 20 angel investors and industry leaders, including CyberArk founder Udi Mokady. Microsoft 365 Copilot CTO Dr. Eyal Carmi has joined Plurai’s advisory board.

While AI agents are easier to create than ever, making them reliable and cost-effective with real customers is far harder. VentureBeat Pulse Research recently found that half of enterprises have deployed an AI agent or LLM feature that passed internal evaluations but still caused a customer-facing failure in production. Teams spend months manually checking their agents, but they can never anticipate every scenario agents will meet in production, and once agents are live, using frontier LLMs to run and to evaluate every interaction is too slow and too expensive to scale.

From simulation to production

Plurai builds a digital twin of an agent and its world based on the customer’s own knowledge base, tools and policies. It then runs thousands of realistic and adversarial users against the agent in a sandbox, covering the long tail of edge cases and exposing policy violations, hallucinations, incorrect actions, broken tool calls, failed tasks and sensitive data leaks.

The same simulation is then used to optimize the agent. Plurai generates fixes for the failures it finds and uses the simulation data to create small language models (SLMs) tailored to each agent. In production, these SLMs play two roles: they can replace frontier LLMs to run the agent, improving accuracy at a fraction of the cost, and they act as always-on evaluators and guardrails, checking every action and enforcing company policy. New failures they catch feed back into the simulation, so the agent keeps improving over time.

Previously limited to select partners and customers, Plurai is now open to every agent builder, with a free tier. Developers can start directly from the tools they already use, including Claude Code, Codex and GitHub Copilot, and teams can simulate and improve agents built on enterprise platforms such as Salesforce Agentforce.

Founders shaped by autonomous driving

Co-founders Dr. Ilan Kadar (CEO, PhD in computer science and machine learning) and Dr. Elad Levi (CTO, PhD in mathematics) have spent the past decade bringing reliable AI systems into production in mission-critical environments. At Nexar, where Kadar was VP of AI and Levi was an AI architect, they led efforts to build real-time, scalable and reliable systems for autonomous driving companies like Waymo, which rely on simulation to validate self-driving systems before they reach the road.

Their research and open-source projects are used by hundreds of thousands of developers worldwide and Plurai’s technology is grounded in the company’s own original research. This includes BARRED, a new method for generating synthetic training data for custom SLMs, which was accepted at ICML 2026, one of the world’s leading machine learning conferences. Other research has shown how to serve hundreds of tailored SLMs in real time on a single GPU, making them economically viable at scale.

“AI systems fail when they hit challenges down the road which no one predicted,” said Dr. Kadar. “Waymo built trust by testing and training across more than 20 billion simulated miles, roughly 100 times its real-world driving. Plurai brings that same approach to AI agents: continuously challenging them with the hardest situations and rarest events before they reach users, learning from failures, and improving before those failures happen in the real world.”

Validation and traction: NVIDIA, Nebius and Gartner

Plurai is already working with enterprises across AI-native and highly regulated industries, including Fortune 500 and major financial companies. In addition to the work with NVIDIA and Nebius, Plurai was named a Representative Vendor in Gartner’s 2026 Market Guide for AI Evaluation and Observability Platforms, a category Gartner projects 60% of software engineering teams will adopt by 2028, up from 18% in 2025. It was also featured in Gartner’s “8 Emerging Practices for Testing AI Agents.”

“As agents move into core enterprise workflows, the missing layer is infrastructure that builds trust in them before they reach customers and keeps them improving in production,” said Aviad Harell, Managing Partner at Team8. “Simulation will become as fundamental to the agent stack as CI/CD is to software. Ilan and Elad bring deep AI expertise and over a decade of bringing AI into high-stakes production systems, and they’re the team to build that layer.”

Additional Quotes

“AI is probabilistic. Enterprises are not,” said Udi Mokady, founder of CyberArk, chairman of CHEQ and an angel investor in Plurai. “The founders have spent more than a decade building AI for mission-critical environments like autonomous driving, where systems don’t get second chances. That experience shows in how they approach agents, and it’s what separates AI that can be deployed from AI that can be trusted.”

“For enterprises, evaluating AI agents on real customer data is often blocked by privacy, security and compliance constraints, which makes simulation mission-critical,” said Dr. Eyal Carmi, CTO of Microsoft 365 Copilot and a member of Plurai’s advisory board. “What sets Plurai apart is how faithfully it recreates each company’s world, from its tools and policies to the users its agents actually face. And it doesn’t stop at finding failures. It turns what it learns into fixes and production safeguards, so teams can deploy agents with confidence.”

“Frontier models are incredibly capable, but using them to continuously evaluate agent behavior in production can quickly become expensive and impractical,” said Reah Miyara, Senior Director of Google Models at Google Cloud, former model evaluation lead at OpenAI and an angel investor in Plurai. “What I find compelling about Plurai is the idea of using smaller, tailored models to make evaluation continuous, not just something you do on a small sample of traffic.”

For more information and to get started, visit: https://www.plurai.ai/

About Plurai

Plurai is the simulation infrastructure for trustworthy, self-improving AI agents. It simulates each agent’s real-world environment to find failures and fix them, then post-trains the agent’s underlying models on what it learns. With Plurai, agents get more reliable, more capable and cheaper to run with every cycle: simulate, fix, post-train, repeat. Founded by Dr. Ilan Kadar and Dr. Elad Levi, Plurai is backed by Team8, U&I, Velocity, Mercer, and leading industry investors. Learn more at plurai.ai.

Media Contact
[email protected]

SOURCE Plurai

Aquiline Invests in Beni Solutions, a Fast-Growing Provider of Affordable Health Plans

Beni gives small to mid-sized employers an affordable, compliant alternative to traditional group health plans.

NEW YORK, Nov. 11, 2026 — Aquiline today announced that it has invested in Beni Solutions, a provider of affordable, ACA-compliant health benefits for small to mid-sized employers in the United States.

Founded in 2022 and headquartered in Wayne, N.J., Beni designs and administers straightforward, guaranteed-issue health plans that allow employers to meet their regulatory obligations while giving employees coverage they can actually use. Beni gives employers a compliant and affordable option for employees and fills a gap for brokers looking for alternatives to traditional plans. Beni manages enrollment, billing, commissions, and servicing and works with approximately 700 agencies and 1,600 agents nationally.

Rising healthcare costs have put traditional group health plans out of reach for a growing number of small to mid-sized employers, many of whom are left choosing between costly coverage and regulatory penalties. Closing this gap is among the more significant challenges facing the U.S. benefits market today.

Brianna Manente, Co-Founder and CEO of Beni, said: “We have built Beni into a leader in the alternative health plan space by giving employers and brokers a plan that is simple, compliant, and affordable. Aquiline shares our vision and brings deep experience in benefits and insurance to help us take Beni to the next level. We could not be more excited for this next chapter.”

Tim Varone, Co-Founder and Chief Revenue Officer of Beni, said: “Brokers are under real pressure to find coverage their clients can afford, and Beni was built to give them a plan they can place. Our growth has come from earning the trust of brokers one at a time, and with Aquiline’s support we can reach many more of them across the country.”

Thomas Lynch, Principal at Aquiline, said: “We identified Beni as a leader in a fast-growing segment of the benefits market. With premiums still rising and no relief in sight, we believe demand for what Beni offers will only grow. We are excited to back Brianna and Tim, who have built a company that brokers trust and employers need, and to invest with them in sales and marketing to bring Beni’s plans to employers nationwide.”

About Aquiline

Aquiline is a global private investment firm with offices in New York, London, and Philadelphia that focuses on financial services and technology. As of June 30, 2026, Aquiline had approximately $11 billion of assets under management and deployed approximately $8.7 billion of capital across the firm’s strategies since inception. 

For more information about Aquiline, its investment professionals, and its portfolio companies, please visit www.aquiline.com.

About Beni Solutions

Beni Solutions is a technology-enabled provider of affordable, ACA-compliant health benefits for employers across the United States. Founded in 2022 and based in Wayne, N.J., Beni serves more than 1,500 employer groups and over 30,000 lives.

For more information, please visit www.beni.solutions.

Media Contacts:
Lawton King
(202) 713-0460
[email protected] 

SOURCE Aquiline Capital Partners LP

TheHolyCoins Launches Crypto Presale ROI Dashboard to Track Token Performance, Revealing 99.34% Average Loss

The crypto presale ROI tracker gives investors one place to compare token prices, track returns and assess the risks of new token sales.

TEL AVIV, Israel, Nov. 11, 2026 — TheHolyCoins (https://theholycoins.com) has launched a crypto presale ROI dashboard tracking 48 projects, with an initial dataset showing a fundraising-weighted average decline of 99.34% from final presale prices. The dashboard helps investors examine what happened to tokens after previous sales before committing money to new ones. TheHolyCoins plans to expand coverage beyond the initial 48 projects.

The crypto presale performance tracker lets users compare final presale prices with current market prices, alongside reported funds raised, all-time highs and listing dates. Investors can search individual projects, filter by category and sort the results to see which tokens have retained value and which have collapsed.

BlockDAG and Pepe Unchained illustrate the scale. The tracker records $440 million in reported fundraising for BlockDAG and $73.9 million for Pepe Unchained. As of November 10, their tokens show returns of −99.96% and −99.82%, respectively, against the final presale prices used by the dashboard.

Those two projects alone account for more than half a billion dollars in reported fundraising. Their performance gives investors researching new crypto presales a reason to look beyond fundraising milestones and projected listing prices.

The list includes apparent scams alongside stalled projects. Bitcoin Pepe’s team disappeared amid complaints of undelivered tokens, while Qubetics halted core development after reporting over $18 million raised. Others, including Pepe Unchained, continue developing products despite steep price declines and exchange delistings.

“Retail investors can face experienced developers and professional marketers who know how to sell the promise of getting in early,” said Shay Feldman, editor-in-chief of TheHolyCoins. “Influencer endorsements, countdowns and ambitious price predictions can make a speculative token sale look like an opportunity investors cannot afford to miss. We built this dashboard so people can check what happened after previous presales ended, before putting their money into another one.”

Coverage focuses on presales conducted from 2021 onward, primarily those raising approximately $1 million or more, with selected smaller projects included. Prices are sourced mainly from CoinGecko, while fundraising information comes from public materials and reporting.

Returns compare market prices with final presale prices; individual investor outcomes depend on entry prices and selling decisions. Calculations exclude vesting schedules, liquidity depth and OTC transactions. The dataset covers selected projects, rather than the entire crypto presale market.

The crypto presale ROI dashboard is available at:
https://theholycoins.com/crypto-presales-roi-performance-tracker

About TheHolyCoins

TheHolyCoins is a cryptocurrency publication covering crypto presales and early-stage token projects through news, investigations, reviews and educational guides. Its coverage examines project claims, tokenomics, transparency and investment risks to help readers research token sales and make better-informed decisions. Visit https://theholycoins.com.

Media Contact

Shay Feldman
Editor-in-Chief, TheHolyCoins
+972-52-8664937
[email protected] 

SOURCE TheHolyCoins